Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BCG
|
|||
| Former ID |
DNC000882
|
|||
| Drug Name |
LLZ16407
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | MAPK/ERK kinase kinase 2 (MAP3K2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Gap junction | ||||
| GnRH signaling pathway | ||||
| NetPath Pathway | IL5 Signaling Pathway | |||
| TGF_beta_Receptor Signaling Pathway | ||||
| TCR Signaling Pathway | ||||
| Panther Pathway | B cell activation | |||
| EGF receptor signaling pathway | ||||
| FGF signaling pathway | ||||
| Pathway Interaction Database | ErbB1 downstream signaling | |||
| Trk receptor signaling mediated by the MAPK pathway | ||||
| WikiPathways | Insulin Signaling | |||
| EGF/EGFR Signaling Pathway | ||||
| MAPK Cascade | ||||
| MAPK Signaling Pathway | ||||
| BDNF signaling pathway | ||||
| IL-1 signaling pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.